Outcomes of Breast Conservation Surgery and Modified Radical Mastectomy After Neoadjuvant Chemotherapy in Patients with Locally Advanced Breast Cancer

被引:2
作者
Akbari, Mohammad Esmaeil [1 ]
Delshad, Belal [1 ]
Mousavizadeh, Mostafa [1 ]
机构
[1] Shahid Beheshti Univ Med Sci, Canc Res Ctr, Tehran, Iran
关键词
Breast Neoplasms; Breast-Conserving Surgery; Modified Radical Mastectomy; Disease-Free Survival; Survival Analysis; CONSERVING SURGERY; PREOPERATIVE IRRADIATION; STAGE-III; RECURRENCE; WOMEN; CHOICE;
D O I
10.5812/ijcm.14297
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Breast cancer is the most common cancer among Iranian women. The treatment of locally advanced breast cancer (LABC) is an important issue in ongoing studies. There is controversy about the ideal treatment in available studies. Objectives: We aimed at comparing the local recurrence rate and disease-free survival in patients with LABC in breast-conserving therapy (BCT) and modified radical mastectomy (MRM) groups after neoadjuvant chemotherapy. Methods: In this cohort, we analyzed the data of patients with LABC referred to the cancer research center of Shohada-E-Tajrish Hospital. Patients were categorized into two groups of BCT and MRM. Different parameters were recorded and compared between the two groups. Endpoint outcome measures were defined as survival rate and local recurrence rate. Results: Generally, 115 patients with an average age of 48.23 years in BCT and 48.76 years in the MRM group were included. Hormone consumption history showed a significant difference between the two surgery groups (P = 0.032). Twenty-one patients (18.26%) showed local recurrence. The disease-free survival rate did not differ between the two surgery groups (P = 0.250). The association of survival was only significant with cigarette smoking (P = 0.041). Conclusions: BCT after neoadjuvant chemotherapy showed an identical disease-free survival rate compared to MRM and did not show lower survival or higher recurrence rate in comparison to radical mastectomy.
引用
收藏
页数:5
相关论文
共 28 条
[1]   Breast Cancer Issues in Developing Countries: An Overview of the Breast Health Global Initiative [J].
Anderson, Benjamin O. ;
Jakesz, Raimund .
WORLD JOURNAL OF SURGERY, 2008, 32 (12) :2578-2585
[2]  
[Anonymous], 2008, WORLD CANC REPORT 20
[3]  
[Anonymous], TOP 10 CAUS DEATH 20
[4]  
Chawla A, 2012, FUTURE ONCOL, V8, P239, DOI [10.2217/fon.12.12, 10.2217/FON.12.12]
[5]   Surgery following neoadjuvant chemotherapy for HER2-positive locally advanced breast cancer. Time to reconsider the standard attitude [J].
Debled, Marc ;
MacGrogan, Gaetan ;
Breton-Callu, Christelle ;
Ferron, Stephane ;
Hurtevent, Gabrielle ;
Fournier, Marion ;
Bourdarias, Lionel ;
Bonnefoi, Herve ;
Mauriac, Louis ;
de Lara, Christine Tunon .
EUROPEAN JOURNAL OF CANCER, 2015, 51 (06) :697-704
[6]   Current definition of locally advanced breast cancer [J].
Garg, Pankaj Kumar ;
Prakash, Gaurav .
CURRENT ONCOLOGY, 2015, 22 (05) :E409-E410
[7]  
Goya M., 2007, Iranian Annual Cancer Registration Report 2005/2006
[8]  
Halverson K J, 1993, Mo Med, V90, P759
[9]   Extent of Primary Breast Cancer Surgery: Standards and Individualized Concepts [J].
Heil, Joerg ;
Fuchs, Valerie ;
Golatta, Michael ;
Schott, Sarah ;
Wallwiener, Markus ;
Domschke, Christoph ;
Sinn, Peter ;
Lux, Michael P. ;
Sohn, Christof ;
Schuetz, Florian .
BREAST CARE, 2012, 7 (05) :364-369
[10]   Ipsilateral breast tumor recurrence (IBTR) in patients with operable breast cancer who undergo breast-conserving treatment after receiving neoadjuvant chemotherapy [J].
Ishitobi, Makoto ;
Ohsumi, Shozo ;
Inaji, Hideo ;
Ohno, Shinji ;
Shigematsu, Hideo ;
Akiyama, Futoshi ;
Iwase, Takuji ;
Akashi-Tanaka, Sadako ;
Sato, Nobuaki ;
Takahashi, Kaoru ;
Oura, Shoji .
CANCER, 2012, 118 (18) :4385-4393